Skip to main content

Spineway : Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical Instruments

Written by Customer Service on . Posted in Public Companies.


Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical InstrumentsSpineway, specialist in designing innovative surgical implants and instruments for treating severe disorders of the spinal column, announces the signature of an exclusive agreement for the distribution of its products in Japan with MURANAKA Medical Instruments.This agreement follows on the heels of the approval last October by the Japanese health authorities of Spineway’s Mont-Blanc MIS minimally invasive surgical line. Thanks to established know-how on the Asian continent, Spineway will be able to rely on the sales network and expertise of one of the biggest importers/distributers of medical equipment in Japan to distribute its products on this territory.Based in Osaka, MURANAKA boasts annual revenue of over 300 million euros and is established in Japan’s largest cities. It has a neurosurgery division and distributes a wide range of equipment and consumables (implants) to the main Japanese hospitals.Stéphane Le Roux, Chairman and CEO of Spineway, said: “We are honored by and pleased with this partnership with MURANAKA, which is the best partner possible for the promotion of our Mont-Blanc MIS line in Japan. As soon as is feasible, we will assist MURANAKA’s teams and provide guidance as to the specifics and advantages of the Spineway systems in order to develop sales of our premium implants in Japan.”Thanks to this agreement, Spineway will be able to distribute its implants on one of the world’s largest spinal-surgery markets and spur its sales with higher added value.Upcoming: 26 May 2020 – General MeetingSPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLANS FOR SMES)Find out all about Spineway at www.spineway.comThis press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its revenue comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), has received the OSEO Excellence award since 2011 and has won the Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation award (2013) – INPI Talent award (2015).
ISIN: FR0011398874 – ALSPWContacts:AttachmentCP_SPW_Japon_VD 202004 GB

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.